Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
738K
-
Shares change
-
0
-
Total reported value, excl. options
-
$6.53M
-
Price
-
$8.85
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2025
4 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q2 2025.
AVADEL PHARMACEUTICALS - COM (AVDL) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 738K shares
.
Largest 4 shareholders include Knoll Capital Management, LLC (600K shares), SCHULHOFF & CO INC (138K shares), HUNTINGTON NATIONAL BANK (1 shares), and DRW Securities, LLC (25K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.